annual operating profit:
$551.48M+$213.90M(+63.36%)Summary
- As of today (June 22, 2025), HALO annual operating income is $551.48 million, with the most recent change of +$213.90 million (+63.36%) on December 31, 2024.
- During the last 3 years, HALO annual operating profit has risen by +$275.57 million (+99.88%).
- HALO annual operating profit is now at all-time high.
Performance
HALO Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$141.53M-$33.97M(-19.35%)Summary
- As of today (June 22, 2025), HALO quarterly operating income is $141.53 million, with the most recent change of -$33.97 million (-19.35%) on March 31, 2025.
- Over the past year, HALO quarterly operating profit has increased by +$45.99 million (+48.14%).
- HALO quarterly operating profit is now -19.35% below its all-time high of $175.50 million, reached on December 31, 2024.
Performance
HALO quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$597.47M+$45.99M(+8.34%)Summary
- As of today (June 22, 2025), HALO TTM operating income is $597.47 million, with the most recent change of +$45.99 million (+8.34%) on March 31, 2025.
- Over the past year, HALO TTM operating profit has increased by +$218.15 million (+57.51%).
- HALO TTM operating profit is now at all-time high.
Performance
HALO TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
HALO Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.4% | +48.1% | +57.5% |
| 3 y3 years | +99.9% | +87.0% | +98.6% |
| 5 y5 years | +915.7% | +4491.4% | +909.6% |
HALO Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +106.1% | -19.4% | +315.6% | at high | +147.0% |
| 5 y | 5-year | at high | +915.7% | -19.4% | +4491.4% | at high | +909.6% |
| alltime | all time | at high | +762.8% | -19.4% | +541.4% | at high | +707.7% |
HALO Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $141.53M(-19.4%) | $597.47M(+8.3%) |
| Dec 2024 | $551.48M(+63.4%) | $175.50M(+7.5%) | $551.48M(+15.6%) |
| Sep 2024 | - | $163.20M(+39.2%) | $477.01M(+18.6%) |
| Jun 2024 | - | $117.23M(+22.7%) | $402.09M(+6.0%) |
| Mar 2024 | - | $95.54M(-5.4%) | $379.31M(+12.4%) |
| Dec 2023 | $337.57M(+26.2%) | $101.03M(+14.4%) | $337.57M(+8.5%) |
| Sep 2023 | - | $88.28M(-6.5%) | $311.05M(+1.6%) |
| Jun 2023 | - | $94.46M(+75.6%) | $306.06M(+24.6%) |
| Mar 2023 | - | $53.80M(-27.8%) | $245.66M(-8.2%) |
| Dec 2022 | $267.53M(-3.0%) | $74.51M(-10.5%) | $267.53M(+7.2%) |
| Sep 2022 | - | $83.29M(+144.5%) | $249.56M(+3.2%) |
| Jun 2022 | - | $34.06M(-55.0%) | $241.85M(-19.6%) |
| Mar 2022 | - | $75.67M(+33.8%) | $300.84M(+9.0%) |
| Dec 2021 | $275.90M(+91.3%) | $56.53M(-25.2%) | $275.90M(-7.1%) |
| Sep 2021 | - | $75.59M(-18.8%) | $296.99M(+13.5%) |
| Jun 2021 | - | $93.05M(+83.4%) | $261.70M(+32.0%) |
| Mar 2021 | - | $50.73M(-34.6%) | $198.21M(+37.4%) |
| Dec 2020 | $144.25M(-313.4%) | $77.62M(+92.6%) | $144.25M(+317.3%) |
| Sep 2020 | - | $40.30M(+36.4%) | $34.57M(-214.2%) |
| Jun 2020 | - | $29.55M(-1017.0%) | -$30.27M(-59.0%) |
| Mar 2020 | - | -$3.22M(-89.9%) | -$73.80M(+9.2%) |
| Dec 2019 | -$67.61M(-2.5%) | -$32.06M(+30.7%) | -$67.61M(+89.8%) |
| Sep 2019 | - | -$24.54M(+75.6%) | -$35.62M(-2.6%) |
| Jun 2019 | - | -$13.98M(-571.2%) | -$36.56M(-14.3%) |
| Mar 2019 | - | $2.97M(-4277.5%) | -$42.65M(-38.5%) |
| Dec 2018 | -$69.33M(-185.6%) | -$71.00K(-99.7%) | -$69.33M(-222.3%) |
| Sep 2018 | - | -$25.47M(+26.9%) | $56.67M(-37.2%) |
| Jun 2018 | - | -$20.07M(-15.3%) | $90.22M(+6.4%) |
| Mar 2018 | - | -$23.71M(-118.8%) | $84.82M(+4.7%) |
| Dec 2017 | $81.00M(-197.3%) | $125.93M(+1459.1%) | $81.00M(-220.0%) |
| Sep 2017 | - | $8.08M(-131.7%) | -$67.50M(-31.3%) |
| Jun 2017 | - | -$25.48M(-7.4%) | -$98.32M(+4.0%) |
| Mar 2017 | - | -$27.53M(+21.9%) | -$94.57M(+13.6%) |
| Dec 2016 | -$83.21M(+203.1%) | -$22.57M(-0.7%) | -$83.21M(+50.8%) |
| Sep 2016 | - | -$22.74M(+4.7%) | -$55.17M(-0.9%) |
| Jun 2016 | - | -$21.72M(+34.3%) | -$55.66M(+87.4%) |
| Mar 2016 | - | -$16.17M(-395.9%) | -$29.71M(+8.2%) |
| Dec 2015 | -$27.45M(-56.5%) | $5.46M(-123.5%) | -$27.45M(-25.3%) |
| Sep 2015 | - | -$23.24M(-649.2%) | -$36.77M(+12.9%) |
| Jun 2015 | - | $4.23M(-130.4%) | -$32.56M(-37.1%) |
| Mar 2015 | - | -$13.91M(+261.2%) | -$51.73M(-17.9%) |
| Dec 2014 | -$63.04M(-21.6%) | -$3.85M(-79.8%) | -$63.04M(-21.7%) |
| Sep 2014 | - | -$19.03M(+27.3%) | -$80.51M(+0.7%) |
| Jun 2014 | - | -$14.94M(-40.8%) | -$79.98M(-8.2%) |
| Mar 2014 | - | -$25.22M(+18.3%) | -$87.16M(+8.4%) |
| Dec 2013 | -$80.43M | -$21.32M(+15.3%) | -$80.43M(+26.6%) |
| Sep 2013 | - | -$18.49M(-16.4%) | -$63.52M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$22.12M(+19.6%) | -$65.05M(+14.2%) |
| Mar 2013 | - | -$18.50M(+319.7%) | -$56.98M(+6.3%) |
| Dec 2012 | -$53.63M(+170.3%) | -$4.41M(-78.0%) | -$53.63M(-20.7%) |
| Sep 2012 | - | -$20.03M(+42.6%) | -$67.65M(+59.3%) |
| Jun 2012 | - | -$14.05M(-7.2%) | -$42.46M(+67.7%) |
| Mar 2012 | - | -$15.14M(-17.8%) | -$25.32M(+27.6%) |
| Dec 2011 | -$19.84M(-63.4%) | -$18.43M(-457.6%) | -$19.84M(+2.8%) |
| Sep 2011 | - | $5.15M(+66.4%) | -$19.29M(-47.7%) |
| Jun 2011 | - | $3.10M(-132.0%) | -$36.88M(-29.3%) |
| Mar 2011 | - | -$9.66M(-46.0%) | -$52.13M(-3.9%) |
| Dec 2010 | -$54.26M(-7.2%) | -$17.88M(+43.8%) | -$54.26M(+10.6%) |
| Sep 2010 | - | -$12.43M(+2.3%) | -$49.05M(-3.0%) |
| Jun 2010 | - | -$12.15M(+3.1%) | -$50.56M(-8.9%) |
| Mar 2010 | - | -$11.79M(-7.0%) | -$55.49M(-5.1%) |
| Dec 2009 | -$58.46M(+15.9%) | -$12.68M(-9.1%) | -$58.46M(-6.9%) |
| Sep 2009 | - | -$13.94M(-18.4%) | -$62.81M(+4.6%) |
| Jun 2009 | - | -$17.08M(+15.8%) | -$60.07M(+10.5%) |
| Mar 2009 | - | -$14.76M(-13.3%) | -$54.36M(+7.8%) |
| Dec 2008 | -$50.43M(+79.2%) | -$17.03M(+52.0%) | -$50.43M(+16.4%) |
| Sep 2008 | - | -$11.20M(-1.5%) | -$43.34M(+7.1%) |
| Jun 2008 | - | -$11.37M(+5.0%) | -$40.45M(+15.9%) |
| Mar 2008 | - | -$10.83M(+9.1%) | -$34.90M(+24.0%) |
| Dec 2007 | -$28.15M(+80.6%) | -$9.93M(+19.5%) | -$28.15M(+23.0%) |
| Sep 2007 | - | -$8.31M(+42.5%) | -$22.89M(+24.4%) |
| Jun 2007 | - | -$5.83M(+42.9%) | -$18.41M(+15.1%) |
| Mar 2007 | - | -$4.08M(-12.6%) | -$15.99M(+2.6%) |
| Dec 2006 | -$15.58M(+14.9%) | -$4.67M(+22.0%) | -$15.58M(+7.5%) |
| Sep 2006 | - | -$3.83M(+12.0%) | -$14.49M(+0.4%) |
| Jun 2006 | - | -$3.42M(-7.0%) | -$14.43M(+3.4%) |
| Mar 2006 | - | -$3.67M(+2.6%) | -$13.96M(+3.0%) |
| Dec 2005 | -$13.56M(+49.2%) | -$3.58M(-5.0%) | -$13.56M(+8.4%) |
| Sep 2005 | - | -$3.77M(+27.8%) | -$12.51M(+4.2%) |
| Jun 2005 | - | -$2.95M(-9.9%) | -$12.01M(+7.7%) |
| Mar 2005 | - | -$3.27M(+29.4%) | -$11.15M(+22.7%) |
| Dec 2004 | -$9.09M(<-9900.0%) | -$2.53M(-22.5%) | -$9.09M(+64.4%) |
| Sep 2004 | - | -$3.26M(+56.2%) | -$5.53M(+106.8%) |
| Jun 2004 | - | -$2.09M(+73.0%) | -$2.67M(+179.5%) |
| Mar 2004 | - | -$1.21M(-217.0%) | -$956.20K(<-9900.0%) |
| Dec 2003 | $0.00(0.0%) | $1.03M(-352.9%) | $0.00(-100.0%) |
| Sep 2003 | - | -$408.20K(+9.5%) | -$1.01M(+64.0%) |
| Jun 2003 | - | -$372.90K(+48.3%) | -$618.40K(+134.4%) |
| Mar 2003 | - | -$251.40K(-1458.9%) | -$263.80K(<-9900.0%) |
| Dec 2002 | $0.00(-100.0%) | $18.50K(-246.8%) | $0.00(-100.0%) |
| Sep 2002 | - | -$12.60K(-31.1%) | -$18.50K(+213.6%) |
| Jun 2002 | - | -$18.30K(-247.6%) | -$5900.00(-147.6%) |
| Mar 2002 | - | $12.40K | $12.40K |
| Dec 2001 | -$39.70K | - | - |
FAQ
- What is Halozyme Therapeutics annual operating income?
- What is the all time high annual operating profit for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual operating profit year-on-year change?
- What is Halozyme Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly operating profit year-on-year change?
- What is Halozyme Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM operating profit year-on-year change?
What is Halozyme Therapeutics annual operating income?
The current annual operating profit of HALO is $551.48M
What is the all time high annual operating profit for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual operating income is $551.48M
What is Halozyme Therapeutics annual operating profit year-on-year change?
Over the past year, HALO annual operating income has changed by +$213.90M (+63.36%)
What is Halozyme Therapeutics quarterly operating income?
The current quarterly operating profit of HALO is $141.53M
What is the all time high quarterly operating profit for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly operating income is $175.50M
What is Halozyme Therapeutics quarterly operating profit year-on-year change?
Over the past year, HALO quarterly operating income has changed by +$45.99M (+48.14%)
What is Halozyme Therapeutics TTM operating income?
The current TTM operating profit of HALO is $597.47M
What is the all time high TTM operating profit for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM operating income is $597.47M
What is Halozyme Therapeutics TTM operating profit year-on-year change?
Over the past year, HALO TTM operating income has changed by +$218.15M (+57.51%)